In Depth 1 Aug 2024
CureVac: From a failed drug to a €1.45 billion deal
In 2021, CureVac’s COVID-19 candidate came short. Discover how the company leveraged its deal with GSK to restructure and turn things around.
GSK
- Latest Posts
In Depth 3 Apr 2024
Hepatitis B: are we edging closer to a cure?
Find out whether we are closing in on a cure for hepatitis B – a virus affecting the liver that can cause acute and chronic disease.
News and Trends 21 Dec 2023
The big pharma race against deadly RSV steps up in 2023
GSK and Pfizer received FDA approval for their RSV vaccines in 2023. Now, AstraZeneca has joined the race with its latest acquisition.
News and Trends 27 Jun 2023
GSK gonorrhea vaccine fast tracked
The US Food and Drug Administration (FDA) has granted a Fast Track designation for GSK plc’s Neisseria gonorrhoeae investigational vaccine (NgG). The vaccine candidate is currently in an ongoing phase II trial and aims to demonstrate proof of concept by assessing the efficacy of the NgG vaccine in healthy adults, 18 to 50 years of […]
More News! 6 Jun 2023
$5.5M funding for Oncopole to tackle cancer
Oncopole, Fonds de recherche du Québec – Santé (FRQS) cancer division in Canada, has received major investments that boost its public-private partnership model dedicated to the fight against cancer. Oncopole will continue to pursue its mission thanks to a $3 million reinvestment from founding partner Merck Canada. Oncopole, FRQS cancer division, is the result of […]
News and Trends 4 May 2023
World’s first RSV vaccine for older adults gets FDA approval
GSK plc says the US Food and Drug Administration (FDA) has approved Arexvy (respiratory syncytial virus vaccine, adjuvanted) for the prevention of lower respiratory tract disease (LRTD) caused by respiratory syncytial virus (RSV) in individuals 60 years of age and older. It is the first RSV vaccine for older adults to be approved anywhere in […]
ADVERTISEMENT
ADVERTISEMENT
Opinion 26 Apr 2023
How to address declining vaccination rates in older adults
By Philip Dormitzer, global head of vaccines research and development, GSK The vaccines landscape has changed greatly over the last few years in light of the COVID-19 pandemic. New technologies have been applied at scale, innovative vaccine programs rolled out, and supply chains rearranged to help tackle global health challenges. But, while innovation has improved […]
News and Trends 8 Mar 2023
How to promote diversity in STEM
Leaders from OMass Therapeutics, SiSaf and Brainomix explain how to promote diversity in science, technology, engineering and math (STEM). OMass Therapeutics is a female-led business with diversity at its core. It was founded by the pioneering scientist and Oxford Professor Dame Carol Robinson and is led by the experienced biotech and pharma executive Ros Deegan. […]
Expert Advice 2 Mar 2023
5 steps to strategic partnerships for healthtech startups
By Varvara Melikhova, founder and CEO of Unison Innovations Strategic partnerships are a better way to build a product’s capabilities than outright acquisitions. While the M&A path is set out for the most mature successful startups, early-stage partnerships can enhance a product’s market value and provide access to Big Pharma expertise and infrastructure, which significantly […]
News and Trends 10 Feb 2023
FDA approves GSK drug for recurrent or advanced mismatch repair-deficient endometrial cancer
GSK plc says the US Food and Drug Administration (FDA) has given full approval for Jemperli (dostarlimab-gxly) for the treatment of adult patients with mismatch repair-deficient (dMMR) recurrent or advanced endometrial cancer, as determined by a US FDA-approved test, that has progressed on or following a prior platinum-containing regimen in any setting and are not […]
News and Trends 9 Feb 2023
Cell and Gene Therapy Catapult boost for life science campus
The Cell and Gene Therapy Catapult (CGT Catapult), an independent U.K. innovation and technology organization specializing in the advancement of cell and gene therapies, has announced its involvement in the development of a major new campus for life science businesses in Stevenage. The new campus was announced by UBS Asset Management’s Real Estate & Private […]
News and Trends 10 Nov 2022
Sanofi and GSK Covid-19 booster vaccine approved by European Commission
Sanofi and GSK’s Covid booster vaccine has been approved in Europe. After the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion for VidPrevtyn Beta, the vaccine was approved by the European Commission, as a booster for the prevention of Covid-19 in adults 18 years of age and older. […]
ADVERTISEMENT
